Del Re, M., Conteduca, V., Crucitta, S., Gurioli, G., Casadei, C., Restante, G., . . . De Giorgi, U. (2021). Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide. Prostate Cancer Prostatic Dis.
Chicago Stili AlıntıDel Re, M., et al. "Androgen Receptor Gain in Circulating Free DNA and Splicing Variant 7 in Exosomes Predict Clinical Outcome in CRPC Patients Treated With Abiraterone and Enzalutamide." Prostate Cancer Prostatic Dis 2021.
MLA AlıntıDel Re, M., et al. "Androgen Receptor Gain in Circulating Free DNA and Splicing Variant 7 in Exosomes Predict Clinical Outcome in CRPC Patients Treated With Abiraterone and Enzalutamide." Prostate Cancer Prostatic Dis 2021.